Clinical utility of polygenic risk scores: a critical 2023 appraisal

In conclusion, the benefit to individual patients or the health care system in general of PRS-based extensions of existing diagnostic or treatment regimens is still difficult to judge.
Source: Journal of Community Genetics - Category: Genetics & Stem Cells Source Type: research